Curaleaf Reverse Stock Split Takes Effect, Uplisting Hurdle Remains
Curaleaf executed a 1-for-3 reverse stock split on Friday, boosting its TSX share price to C$15.88, in a bid to meet U.S. listing requirements, as competitor Trulieve gained NYSE approval.
Markets
